Stocks
Applied Therapeutics (APLT) EV/EBITDA US GAAP (year values) |
|||||||||
| 2020 | 2021 | 2022 | 2023 | 2024 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | -4.12 | -1.42 | 0.00 | -3.61 | -0.41 | -3.24 | ||
| Changes by years, y/y, % | -40% | -65% | -100% | +205 751% | -89% | -43.1% | |||
Applied Therapeutics. EV/EBITDA
Applied Therapeutics. EV/EBITDA, changes, %
Applied Therapeutics (APLT) EV/EBITDA US GAAP (quarter values) |
||||||||
| 2024Q3 | 2024Q4 | 2025Q1 | 2025Q2 | 2025Q3 | LTM ? | |||
| EV/EBITDA | ? | -12.3 | -0.40 | -0.21 | -0.16 | -0.78 | -3.24 | |
| Changes by years, y/y, % | +303% | -89% | -98% | -98% | -94% | |||
| Changes by quarters, q/q, % | +73% | -97% | -47% | -26% | +402% | |||
